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Abstract
Background Secondary hyperparathyroidism (SHPT)
(i.e., renal hyperparathyroidism) is one of the most serious
complications in long-term hemodialysis patients. The pur-
pose of this retrospective study was toexplore the feasibility
of a new surgical approach—endoscopic total parathyroid-
ectomy with autotransplantation (ETP?AT)—and evaluate
its practical application for patients with SHPT.
Methods The study included 34 SHPT patients who
underwent ETP?AT from among 67 cases at the Depart-
ment of Minimally Invasive Surgery, the First Afﬁliated
Hospital of Nanjing Medical University over a 3-year
period. The other 33 patients underwent traditional total
parathyroidectomy with autotransplantation (TP?AT).
Two criteria were used as indications to perform ETP?AT
in SHPT patients. The ﬁrst was a high serum parathyroid
hormone level (PTH [800 pg/ml) associated with hyper-
calcemia and/or hyperphosphatemia that which were
refractory to medical treatment. The second criterion was
the presence of clinical symptoms including pruritus, bone
and joint pain, muscle weakness, progression of soft tissue
calciﬁcation, and spontaneous fractures. Ultrasonography,
99mTc sestamibi scans, and computed tomography were
used to evaluate the thyroid and parathyroid glands.
Results There was no surgery-related mortality among
any of the patients with ETP?AT. One patient underwent
conventional neck exploration because of bleeding and
injury of a unilateral recurrent laryngeal nerve after the
operation. Preoperative symptoms were alleviated, and the
serum PTH and alkaline phosphatase levels, hyperphos-
phatemia, and hypercalcemia were improved or normalized
in most patients. Recurrence was observed in one patient
with a sixth parathyroid gland behind his thyroid, and the
patient required a second operation. Hypoparathyroidism
was not found after the operation. The clinical data were
compared between ETP?AT and TP?AT.
Conclusions ETP?AT is a safe option for the treatment
of SHPT with low morbidity and mortality, shorter hospital
stay and low recurrence rate. It is important to avoid
intraoperative bleeding, identify all parathyroid glands
during the surgery, and choose adequate parathyroid tissues
for autografting.
Introduction
Secondary hyperparathyroidism (SHPT) is a common
complication of end-stage renal failure. Despite improved
medical management, 0.7% to 1.4% of dialysis-dependent
patients require parathyroidectomy annually [1], The
association between parathyroid hyperplasia and chronic
renal failure (CRF) has been known since the early 1930s
[2]. SHPT is an adaptive response to CRF with disruptions
in the homeostatic control of serum phosphorus, calcium,
and vitamin D. High levels of parathyroid hormone (PTH),
phosphate, and the calcium-phosphate product in the cir-
culation system is associated with uremic bone disease,
vascular calciﬁcation, and death [3, 4]. It has also been
suggested that hyperplasia of parathyroid glands occurs
during the early stages of renal disease even before dialysis
is performed [5].
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rently available, with the overall purpose of reducing the
serum PTH and phosphate levels, elevating the serum
calcium level, and improving skeletal turnover [5–7].
However, several studies have demonstrated that most
patients with extremely high serum PTH levels fail to
respond to vitamin D treatment, and surgical operations are
required [7, 8]. Parathyroidectomy can signiﬁcantly
decrease the PTH and phosphate levels but is typically
performed for patients with refractory SHPT. Parathy-
roidectomy is required for approximately 10% to 30% of
the patients with more than 10 years of hemodialysis [9].
In the present study, we retrospectively analyzed 34
hemodialysis patients who were subjected to endoscopic
total parathyroidectomy with autotransplantation (ETP?
AT) in our department over a 3-year period. Speciﬁcally,
here we identify the indications to perform the surgery for
SHPT patients, describe the procedure of the surgery, and
evaluate the prognosis by biochemical and imaging
analysis.
Materials and methods
Between June 2004 and June 2007, we performed
ETP?AT in 34 patients with advanced renal hyperpara-
thyroidism (SHPT) and total parathyroidectomy with
autotransplantation (TP?AT) in 33 patients with SHPT,
who comprised the control group. Hemodialysis was con-
tinued for all the patients during this period.
The study group included 15 women and 19 men with a
mean ± SD age of 48.7 ± 3.5 years. The average period
of hemodialysis before the surgery was 98 months. CRF
was due to chronic glomerulonephritis in 22 cases, chronic
pyelonephritis in 10 cases, and unknown reasons in 2 cases.
In all patients, conventional treatment—including cal-
cium supplementation, dietary restriction of phosphate-
binding agents, and pulsed oral/intravenous vitamin D
sterol therapy—failed to decrease the serum PTH level.
Two criteria were established as the indications to perform
the surgery. The ﬁrst criterion was severe hyperparathy-
roidism (PTH level [800 pg/ml in all cases) associated
with hypercalcemia and/or hyperphosphatemia that was
refractory to conventional treatment. The second criterion
was the presence of clinical symptoms. In the ETP?AT
group, we performed surgery in 21 (61.8%) patients with
pruritus, 28 (82.4%) with bone and joint pain, 7 (20.6%)
with muscle weakness, 4 (11.8%) with progressive
soft tissue calciﬁcation, and 1 (2.9%) with spontaneous
fractures.
Serum calcium, phosphate, and total alkaline phospha-
tase were determined by standard methods. The serum PTH
level (normal 15–65 pg/ml) was [800 pg/ml in all cases,
with the highest being[2500 pg/ml. Serum calcium levels
(normal 2.15–2.65 mmol/l) ranged from 2.27 to 3.32
mmol/l; 27 patients (79.4%) had hypercalcemia (serum
calcium [2.63 mmol/l), and the remaining patients were
normal or had slight hypercalcemia. Hypercalcemia was
considered to be a consequence of treatment with vitamin
D or vitamin D metabolites. Serum phosphorous acid
(normal 0.86–1.86 mmol/l) ranged between 1.3 and
3.4 mmol/l. Six patients had normal phosphorous acid
levels, and the remaining patients had increased levels.
Normal level of Serum alkaline phosphatase levels were
normal (\150 U/l) in four patients, and the remaining
patients had elevated levels.
Preoperative localization was based primarily on para-
thyroid ultrasonography (US) and
99mTc-sestamibi radio-
nuclide scans, both of which were performed for all
patients before the operation. The sensitivities of US and
99mTc-sestamibi radionuclide scans in determining the
location and number of parathyroid glands were 73.5 and
85.3%, respectively. Computed tomography (CT) was not a
routine examination but was used when necessary. Plain
radiographic examination of hands, feet, chest, and pelvis
were performed to identify the lesions of renal osteodys-
trophy. Bone biopsy was not performed.
All patients were on chronic hemodialysis and were
hemodialyzed the day before surgery and 1 or 2 days after
the surgery. Prior to parathyroid surgery, all patients were
administered with calcitriol to decrease secretion of PTH.
The procedure of ETP?AT is follows. Under general
anesthesia, the patient was placed in the lithotomy position
with the neck elevated by a sandbag. The surgery operator
stood between the legs of the patient and an assistant stood
at the right side of the patient. Three incisions were made at
the crossing point of the bilateral medioclavicular lines,
parasternal line, and the second intercostal level with the
length of each incisions being 0.5, 0.5, and 1 cm, respec-
tively (Fig. 1). We created a subcutaneous space by
injecting 1% epinephrine solution, an expanding dilator,
and carbon dioxide (CO2) with a pressure of 8 mmHg; we
then placed three trocars according to the size of the
incisions. Hypodermic porous connectivum of the thorax
and cervical area was dissociated by an ultrasonic scalpel;
the edge was on the lateral border of both sternocleido-
mastoid muscles and the inferior margin of thyroid carti-
lage. A longitudinal incision of the linea alba cervicalis
was made, and the bilateral infrahyoid muscle groups were
transected to expose the thyroid gland. Th posterior surface
of the thyroid was explored to ﬁnd the parathyroid glands
(Fig. 2) according to the surgical anatomy of the parathy-
roids and the preoperative image diagnosis. The hyper-
plastic parathyroids were dissected, removed (Fig. 3), and
preserved in ice. A portion of each parathyroid was exam-
ined and conﬁrmed by pathological analysis. The cervical
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123muscle that had been cut was sutured with 3-0 absorbable
intermittent stitches after two drainage tubes were placed.
For autotransplantation, 30 pieces of the sliced hyperplastic
glands (1 9 1 9 1m m
3) were implanted into muscles in
the forearm without formation of an arteriovenous (A-V)
ﬁstula for hemodialysis (Fig. 4a, b).
Hemodialysis was performed on the ﬁrst or second day
after surgery. Serum calcium levels were tested at 8-h
intervals over the ﬁrst 48 h after the operation and then
tested every day until they had stabilized. Supplemental
calcium was given intravenously or orally. Vitamin D was
provided on the ﬁrst day after the operation and continued
for 6 to 8 months.
Postoperative recurrence was diagnosed if symptoms
such as pruritus, bone and joint pain, or others occurred and
Fig. 1 Choice of incisions. Three incisions were made at the crossing
point of the bilateral medioclavicular lines, parasternal line, and
second intercostal level, with the length of the incisions being 0.5,
0.5, and 1.0 cm, respectively
Fig. 2 Exposure of the parathyroids. The posterior surface of the
thyroid was explored to search for the parathyroid glands
Fig. 3 Excised parathyroid glands. Hyperplastic parathyroids were
dissected and removed
Fig. 4 a, b Autotransplantation. Sliced hyperplastic parathyroid
tissues were implanted in forearm muscles
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123the serum PTH level increased to [200 pg/ml. US and
99mTc sestamibi scans helped us identify high uptake
behind the thyroid and/or in the forearm.
Results
The average follow-up period after operation was 1.8 years
(1 month to 3 years). The number of excised parathyroid
glands was six in 2 patients, four in 29 patients, three in 2
patients and two in 1 patient. The weight of the removed
glands ranged from 230 to 1280 mg (median 790 mg). The
average time of the operation was 2.5 h, and the average
volume of bleeding was approximately 20 ml. The clinical
data are compared between ETP?AT and TP?AT in
Table 1.
There was no surgery-associated mortality, and the
incidence of postoperative complications was relatively
low. Two patients with high serum alkaline phosphatase
levels before operation were found to have asymptomatic
postoperative hypocalcemia; however, the hypocalcemia
responded to intravenous injection of calcium gluconate
and high doses of calcitriol and dialysate calcium. There
was no postoperative bleeding that required surgical
intervention and no permanent hypocalcemia. Recurrence
of hyperparathyroidism occurred in one patient who had a
ﬁfth parathyroid gland hidden behind the thyroid, and
resection was performed. Unfortunately, we found a sixth
parathyroid behind the thyroid after the second operation
and are currently preparing for a third resection.
Among the 34 EPT?PT operations, only one was con-
verted to the traditional open operation, which was because
of intraoperative bleeding. Using the traditional open
operation in this case, bleeding was prevented and four
parathyroids were successfully removed. No laryngeal
nerves were apparently injured during the operation,
although vocal hoarseness was observed afterward. These
symptoms were relieved after conservative treatment. This
patient experienced temporary hoarseness and recovered
within 2 months. No septic complications were noted in the
neck or forearm wounds.
The clinical symptoms and biochemical index of SHPT
patients after ETP?AT were signiﬁcantly improved. Pru-
ritus was relieved in 18 of 21 patients (85.7%), bone pain
disappeared or was signiﬁcantly relieved in 26 of 28
patients (92.9%), and myopathy disappeared in all patients
within 4 months after the operation. Calcium depositions in
soft tissues either disappeared or were signiﬁcantly
diminished within 6 months after parathyroidectomy.
There was no occurrence of pathologic bone fractures. By
the third postoperative day, the serum calcium level
dropped to within or below the normal range in all patients
except the one with the recurrences. During the follow-up
years, the average (mean ± SD) levels were as follows:
serum calcium 2.24 ± 0.12 mmol/l, serum phosphorus
acid 1.16 ± 0.35 mmol/l, and serum alkaline phosphatase
145 ± 68U/l. In 33 of all of the patients, the serum PTH
decreased to within the normal range.
Supplementation of vitamin D and calcium for the
patients could be terminated or reduced after the grafted
tissues took over the function of the glands. Recurrence of
graft-dependent hyperparathyroidism was not observed in
any of the patients.
Radiologic examination showed that osteodystrophy and
soft tissue calciﬁcations were relieved for most (66.7%) of
the patients 1 or 2 years after the surgery.
Discussion
Despite of the improvements in medical management,
severe SHPT remains a common complication of CRF.
According to a report of the European Dialysis and
Transplant Association, parathyroidectomy is required in
15% of patients after 10 years of dialysis and in 38% of
patients after 20 years of dialysis [10].
The primary indication for surgery in SHPT patients is
an elevated serum PTH level. All 34 patients in the
EPT?AT arm of our study had severe hyperparathyroidism
(PTH [800 pg/ml). Conventional medical therapy had
failed to decrease the PTH level, or it was complicated by
the occurrence of hypercalcemia, which requires discon-
tinuation of calcium/vitamin D therapy. Similar results
were reported by Salem [11] in a survey of 612 chronic
hemodialysis patients; he reported that 50% of patients had
serum PTH levels that were three times higher than normal
despite conventional medical therapy to prevent hyper-
parathyroidism. Hypercalcemia also enhances the need for
surgery in SHPT patients [5, 7, 8]. In our study, 27 patients
had hypercalcemia, and 28 had hyperphosphatemia. The
clinical symptoms of SHPT that were refractory to
Table 1 Comparison of clinical data between ETP?AT and TP?AT
Parameter ETP?AT TP?AT P
Sex (male/female) 15/19 13/20 [0.05
No. of excised parathyroid glands 136 128 [0.05
Duration of the operation (h) 2.5 ± 0.9 2.9 ± 1.4 [0.05
Intraoperative blood loss (ml) 20 80 \0.05
Postoperative bleeding 0 0 –
Conversion to open surgery 1 (2.9%) – –
Hoarseness 1 (2.9%) 1 (3.0%) [0.05
Recurrence 1 (2.9%) 3 (9.1%) \0.05
Hospital stay (days) 4.3 ± 1.1 6.5 ± 1.8 \0.05
ETP endoscopic total parathyroidectomy, AT autotransplantation
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123conventional medical treatment include pruritus, bone and
joint pain, muscle weakness, progression of soft tissue
calciﬁcation, and spontaneous bone fractures.
Many authors have recommended that imaging of
parathyroid glands is required only prior to reoperation.
They also proposed that parathyroid imaging is not usually
needed before the initial parathyroidectomy [12]. Others,
however, have considered a preoperative imaging diagno-
sis highly useful for detecting parathyroid glands, espe-
cially those that are ectopically located [13, 14]. The most
important point of the imaging diagnosis is to visualize all
the parathyroid glands, including supernumerary glands
that are located mainly in fat surrounding the glands or
within the thymus or around the carotid artery [15, 16].
Generally, supernumerary glands are found in 15% to 20%
of patients [16, 17]. We routinely performed US and
99mTc
scintigraphy in all patients before the operation to identify
all of the supernumerary and/or ectopic parathyroid glands.
99mTc-sestamibi showed higher sensitivity for function-
accentuated localization of diseased glands. By using the
sestamibi scan, we successfully identiﬁed all of the
hyperplastic tissues in 29 patients, 2 hyperplastic tissues in
1 patient, and 3 hyperplastic tissues in 3 patients; only one
patient had false-negative result for hyperplastic tissue. US
was our primary localization procedure as it is noninvasive
and not cost-intensive; and it was successful in localizing
the parathyroids in 25 patients. We also found that US was
more helpful for identifying parathyroid glands during the
operation. Finally, CT scan was not an essential examina-
tion for the surgery, whereas plain radiographic examina-
tion of the hands, feet, chest, and pelvis was needed to
identify lesions due to renal osteodystrophy.
There are many variations in parathyroidectomy proce-
dures, especially with endoscopic surgery. To prevent
recurrence, it is essential to remove all of the hyperplastic
parathyroids, and a sufﬁcient quantity of tissue must be
used for transplantation.
Endoscopic bilateral exploration was performed in the
patients in our study to identify all the parathyroid glands.
Except one case that was converted to open operation, we
removed 132 parathyroid glands from 33 patients. Among
the 33 cases, we removed only three parathyroid glands in
two patients and only two parathyroid glands in one
patient. Follow-up observation showed that the treatment
was satisfactory, and there was not hyperthyreosis. This
suggests that not everyone has four parathyroid glands
[18]. The operation (ETP) became more difﬁcult without
the sense of ﬁnger touch. Luckily, good endoscopic illu-
mination made up this deﬁciency in some degree and
avoided bleeding, which otherwise might cloud the surgical
ﬁeld and make it difﬁcult for the operator to ﬁnish the
surgery. In our study, one operation was converted to
conventional surgery because of bleeding and injury of the
recurrent laryngeal nerve after the operation. Therefore,
less bleeding is of crucial importance to ensure the success
of ETP. Blunt dissection is a major procedure in ﬁnding the
parathyroid because the ultrasonic scalpel can lead to
conductive injury of nerves and/or vessels. Postoperative
bleeding that required surgical intervention was not
observed in our study. Mild asymptomatic hypocalcemia
was observed in two cases, even though they were given
oral calcium supplements and calcitriol. None of our
patients suffered from respiratory diseases due to edema or
injury of the recurrent laryngeal nerve, although temporary
hoarseness was observed in one patient. Finally, no septic
complications were noted in the neck or forearm wounds.
There was no recurrence of hyperplastic parathyroid tissue
in the forearm muscles, possibly due to the short follow-up
periods. Even if it occurs, though, we can easily excise it
under local anesthesia or inject anhydrous alcohol to
destroy the hyperplastic parathyroid tissues after localiza-
tion with US and
99mTc sestamibi scan.
In our study, bone pain was mostly found periarticularly
in the shoulders, ankles, and heels, although sometimes it
was generalized. Quick relief of bone pain was noted in
92.9% of patients within days after the operation. Pruritus
disappeared after surgery in 85.7% of the patients. Myop-
athy disappeared in all patients, and soft tissue calcium
deposits either disappeared or were markedly diminished
within months after the surgery (Table 2).
Table 2 Comparison of biochemical detection for patients before and after ETP?AT
Biochemical measurement Normal range Before operation After operation
1 Day 1 Week 3 Months
PTH (pg/ml) 15–65 1775.59 ± 88.94 112.62 ± 337.77 67.84 ± 50.64 51.49 ± 24.75
BUN (mmol/l) 2.10–7.20 24.32 ± 8.20 21.85 ± 10.34 19.32 ± 7.45 22.83 ± 5.34
Cr (lmol/l) 36.0–144.0 862.53 ± 242.07 934.49 ± 174.40 903.54 ± 19.47 813.71 ± 252.38
Ca (mmol/l) 2.15–2.65 2.61 ± 0.36 2.01 ± 0.19 2.18 ± 0.52 2.24 ± 0.12
P (mmol/l) 0.86–1.86 2.55 ± 0.58 1.34 ± 0.32 1.29 ± 0.54 1.16 ± 0.35
ALP (U/l) 15–150 899.28 ± 358.87 422.32 ± 129.04 210.64 ± 44.95 145.05 ± 68.27
PTH parathyroid hormone, BUN blood urea nitrogen, Cr creatinine; P phosphorous acid, ALP alkaline phosphatase
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123Conclusions
Endoscopic total parathyroidectomy with autotransplanta-
tion in the forearm is a highly effective, adequate treatment
for advanced renal hyperparathyroidism. ETP?AT is a safe
operation with low morbidity and mortality, shorter hospital
stay,excellentoutlook(Fig. 5),andlowrecurrence rate.Itis
important to identify and remove all the parathyroid glands
and choose proper and adequate parathyroid tissue for
autografting to prevent recurrence of hyperparathyroidism.
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